Great news! Finally, for the first time in about a decade, we have a new FDA approved neurotoxin arriving in the US for our patients!
Jeuveau™ (prabotulinumtoxinA-xvfs) is the first neurotoxin devoted exclusively to aesthetics and will be a vigorous competitor to Botox®, Dysport®, and Xeomin® that we have using for years. Jeuveau™ has been extensively tested, both internationally and in the US in clinical trials. The research has included safety tests and head-to-head comparisons with Botox® Cosmetic. Our practice is among the first to provide this new product for our patients.
What is Jeuveau™?
Jeuveau™ is a newly FDA approved neurotoxin intended to reduce facial lines from chronic muscle contraction.
Benefits of Jeuveau™
Jeuveau™ is an alternative neurotoxin that appears to work as well as Botox® in most people, and may be more effective for certain individuals, including those who have developed immune resistance to other types of botulinum toxin. It is difficult to measure the potential effect of neutralizing antibodies in individual patients on the effects of particular brands of botulinum toxin. Instead, a treating physician may try one of the other brands to see if effectiveness can be enhanced. Like Botox®, Dysport®, and Xeomin®, Jeuveau™ may have advantages for particular patients.
How does Jeuveau™ compare to Botox®?
In peer-reviewed published research studies, Jeuveau™ works similarly to Botox®, accomplishing about the same amount of muscle relaxation and line reduction, and lasting about the same amount of time.
Results of Jeuveau™
Can I have Jeuveau™ if I have previously had Botox® or Dysport®?
Yes! If you have previously had Botox or another neurotoxin, you are still a candidate for Jeuveau™.
How long does Jeuveau™ last?
Jeuveau™ has a similar duration of action to Botox®, averaging 12 weeks.